drugset / Trial / NCT05264870

Norepinephrine in Caesarian Section

NCT05264870

Phase 4 Terminated 11 enrolled University Hospital, Antwerp
RandomizedParallel-groupDouble-blindTreatment

Summary

Postspinal hypotension is a frequent maternal complication in caesarian delivery under neuraxial anesthesia which is most commonly treated with the administration of phenylephrine infusion. In this trial, postspinal hypotension will be treated with norepinephrine. The main objective is to examine the pharmacodynamic and biochemical effect of norepinephrine both on mother and newborn.

Timeline

Start
2022-06-09
Primary completion
2023-03-02
Completion
2025-08-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Norepinephrine Other / unclassified 10 ug/ml Intravenous

Indications

No indication recorded.